Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 19;14(1):7-18.
doi: 10.1038/nrrheum.2017.198.

Autoimmunity and primary immunodeficiency: two sides of the same coin?

Affiliations
Review

Autoimmunity and primary immunodeficiency: two sides of the same coin?

Reinhold E Schmidt et al. Nat Rev Rheumatol. .

Abstract

Autoimmunity and immunodeficiency were previously considered to be mutually exclusive conditions; however, increased understanding of the complex immune regulatory and signalling mechanisms involved, coupled with the application of genetic analysis, is revealing the complex relationships between primary immunodeficiency syndromes and autoimmune diseases. Single-gene defects can cause rare diseases that predominantly present with autoimmune symptoms. Such genetic defects also predispose individuals to recurrent infections (a hallmark of immunodeficiency) and can cause primary immunodeficiencies, which can also lead to immune dysregulation and autoimmunity. Moreover, risk factors for polygenic rheumatic diseases often exist in the same genes as the mutations that give rise to primary immunodeficiency syndromes. In this Review, various primary immunodeficiency syndromes are presented, along with their pathogenetic mechanisms and relationship to autoimmune diseases, in an effort to increase awareness of immunodeficiencies that occur concurrently with autoimmune diseases and to highlight the need to initiate appropriate genetic tests. The growing knowledge of various genetically determined pathologic mechanisms in patients with immunodeficiencies who have autoimmune symptoms opens up new avenues for personalized molecular therapies that could potentially treat immunodeficiency and autoimmunity at the same time, and that could be further explored in the context of autoimmune rheumatic diseases.

PubMed Disclaimer

References

    1. Nature. 1996 Jan 25;379(6563):346-9 - PubMed
    1. Adv Immunol. 2017;133:121-169 - PubMed
    1. Front Immunol. 2013 Oct 23;4:331 - PubMed
    1. N Engl J Med. 2008 Feb 28;358(9):900-9 - PubMed
    1. J Paediatr Child Health. 2003 May-Jun;39(4):274-7 - PubMed

MeSH terms